SCHEMBL1016186

SCHEMBL1016186

COC(=O)c1cc(Cl)ccc1NC(=O)C(=O)NCc1cccc(Br)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.54
SERPINE1 P05121 2/20 0.52
GAA P10253 3/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CNR1 P21554 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
GABRP O00591 2/20 0.42
GABRD O14764 2/20 0.42
GABRA1 P14867 2/20 0.42
GABRB1 P18505 2/20 0.42
GABRG2 P18507 2/20 0.42
GABRB3 P28472 2/20 0.42
GABRA5 P31644 2/20 0.42
GABRA3 P34903 2/20 0.42
GABRA2 P47869 2/20 0.42
GABRB2 P47870 2/20 0.42
GABRA4 P48169 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1017187 0.85 SERPINE1 (0.57) SERPINE1GAAALDH1A1KDM4ESMN1; SMN2
SCHEMBL1015063 0.81 SERPINE1 (0.58) THRBSERPINE1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL1016838 0.81 SERPINE1 (0.81) THRBSERPINE1GAAALDH1A1KDM4E
SCHEMBL418984 0.77 GRIK1 (0.64) SERPINE1GAAALDH1A1KDM4EHPGD
SCHEMBL26695134 0.76 TP53 (0.49) THRBSERPINE1GAAALDH1A1KDM4E
SCHEMBL30710212 0.76 TP53 (0.49) THRBSERPINE1GAAALDH1A1KDM4E
SCHEMBL26695069 0.76 TP53 (0.54) THRBGAAALDH1A1KDM4ESMN1; SMN2
SCHEMBL30710196 0.76 TP53 (0.54) THRBGAAALDH1A1KDM4ESMN1; SMN2
SCHEMBL418741 0.75 ALDH1A1 (0.55) THRBSERPINE1GAAALDH1A1KDM4E
SCHEMBL15648896 0.74 KMT2A (0.60) GAAALDH1A1SMN1; SMN2LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 THRB 3392/4885SERPINE1 1/4885GAA 459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.